Prospects of Replication-Deficient Adenovirus Based Vaccine Development against SARS-CoV-2
The current appearance of the new SARS coronavirus 2 (SARS-CoV-2) and it quickly spreading across the world poses a global health emergency. The serious outbreak position is affecting people worldwide and requires rapid measures to be taken by healthcare systems and governments. Vaccinations represe...
Main Authors: | Mariangela Garofalo, Monika Staniszewska, Stefano Salmaso, Paolo Caliceti, Katarzyna Wanda Pancer, Magdalena Wieczorek, Lukasz Kuryk |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-06-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/8/2/293 |
Similar Items
-
Combination Therapy of Novel Oncolytic Adenovirus with Anti-PD1 Resulted in Enhanced Anti-Cancer Effect in Syngeneic Immunocompetent Melanoma Mouse Model
by: Mariangela Garofalo, et al.
Published: (2021-04-01) -
Polymer Coated Oncolytic Adenovirus to Selectively Target Hepatocellular Carcinoma Cells
by: Mariangela Garofalo, et al.
Published: (2021-06-01) -
From Conventional Therapies to Immunotherapy: Melanoma Treatment in Review
by: Lukasz Kuryk, et al.
Published: (2020-10-01) -
Structural requirements for adenovirus DNA replication
by: Hu, Chin-Hwa
Published: (2013) -
Genetic Adjuvants in Replicating Single-Cycle Adenovirus Vectors Amplify Systemic and Mucosal Immune Responses against HIV-1 Envelope
by: William E. Matchett, et al.
Published: (2020-02-01)